I am interested in neuroscience and immunology, especially in the interplay between immune cells and the nervous system in neurosurgical disorders such as glioma. My research career began after college when I studied the mechanisms of action of novel therapeutics for chronic lymphocytic leukemia (CLL) under the direction of John C. Byrd, MD, at Ohio State University. I then earned my medical degree from the University of California, San Diego (UCSD), where I also completed cognitive neuroscience research in the laboratory of Martin P. Paulus, MD, now director of the Laureate Institute for Brain Research. My clinical experiences at UCSD exposed me to neurosurgical practice, which attracted my interest on scientific, practical, and human levels. I greatly enjoy being in the operating room and helping people with neurosurgical problems. For many neurosurgical diseases, there is no cure, and for this reason I feel a strong pull to lend my knowledge and efforts towards research in this area. Currently, I work in the lab of Omid Akbari, PhD, on regulatory T cells and innate lymphoid cells, furthering our understanding of these important immune players and enhancing my own research tool set as preparation for future projects in the immunology of neurosurgical diseases, and independent work in this field.
Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity. Nat Commun. 2016 Oct 18; 7:13202. View in: PubMed
Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage. J Thromb Thrombolysis. 2014; 37(2):76-9. View in: PubMed
Accumulation of neural activity in the posterior insula encodes the passage of time. Neuropsychologia. 2010 Aug; 48(10):3110-20. View in: PubMed
Anterior insular cortex anticipates impending stimulus significance. Neuroimage. 2009 Apr 15; 45(3):976-83. View in: PubMed
Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use. Addiction. 2007 Apr; 102 Suppl 1:33-43. View in: PubMed
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein. Blood. 2003 Jul 15; 102(2):652-8. View in: PubMed
The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood. 2002 Feb 1; 99(3):1038-43. View in: PubMed